Greater Cannabis Company Inc
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson's disease, Alzheimer's disease, … Read more
Greater Cannabis Company Inc (GCAN) - Total Liabilities
Latest total liabilities as of September 2025: $1.13 Million USD
Based on the latest financial reports, Greater Cannabis Company Inc (GCAN) has total liabilities worth $1.13 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Greater Cannabis Company Inc - Total Liabilities Trend (2015–2024)
This chart illustrates how Greater Cannabis Company Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Greater Cannabis Company Inc Competitors by Total Liabilities
The table below lists competitors of Greater Cannabis Company Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
STRIKE ENERGY (RJN.SG)
STU:RJN
|
Germany | €74.75 Million |
|
CLST Holdings Inc
PINK:CLHI
|
USA | $40.79 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Greater Cannabis Company Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.02 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 52.90 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Greater Cannabis Company Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Greater Cannabis Company Inc (2015–2024)
The table below shows the annual total liabilities of Greater Cannabis Company Inc from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $898.06K | +7.74% |
| 2023-12-31 | $833.51K | +1.00% |
| 2022-12-31 | $825.28K | -4.26% |
| 2021-12-31 | $862.00K | +87.43% |
| 2020-12-31 | $459.91K | -71.24% |
| 2019-12-31 | $1.60 Million | +124.17% |
| 2018-12-31 | $713.43K | +88.75% |
| 2017-12-31 | $377.97K | +247.44% |
| 2016-12-31 | $108.79K | +2.83% |
| 2015-12-31 | $105.79K | -- |